LIDOCAINE 4% CREAM- lidocaine cream 
Teligent Pharma, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Lidocaine 4% Cream

DESCRIPTION

Lidocaine 4% cream is a non-greasy cream specially formulated with soothing agents, indicated as a topical anesthetic for use on normal intact skin for local analgesia and itching due to minor cuts, minor scrapes, sunburn, minor skin irritations, minor burns and insect bites.

INGREDIENTS

ACTIVE: Lidocaine (4%)

INACTIVE:

Butylated Hydroxytoluene, Cetostearyl Alcohol, Citric Acid, Edetate Disodium, Light Mineral Oil, Methylparaben, Polyoxyl 20 Cetostearyl Ether, Propylene Glycol, Propylparaben, Purified Water, Sodium Citrate and White Petrolatum.

The chemical designation of Lidocaine is 2-(diethylamino)-N(2,6-dimethylphenyl), acetamide. The structure of lidocaine is:


chemical structure

MECHANISM OF ACTION

Lidocaine 4% cream applied to intact skin provides dermal analgesia by the release of lidocaine from the cream into the epidermis and dermis. Lidocaine is a local anesthetic agent of the amide type. Local anesthetics reversibly block the initiation and conduction of nerve impulses by interfering with the flux of sodium ions through the neuronal membrane. The onset, depth and duration of dermal analgesia provided depend upon the site and duration of application.

INDICATIONS AND USAGE

Lidocaine 4% cream is indicated for use on normal intact skin for temporary relief of pain and itching due to minor cuts, minor scrapes, minor skin irritations, minor burns and insect bites.

Lidocaine 4% cream is not recommended for internal use, in the or near the eyes and in large quantities, particularly over raw surfaces or blistered areas.  

CONTRAINDICATIONS

Lidocaine 4% cream is contraindicated in patients with sensitivity to amide type local anesthetics or to any component of the product.

WARNINGS

For external use only. Avoid contact with the eyes. Do not use over large areas of the body. Do not use for more than seven days unless directed by a doctor. Keep this and all drugs out of the reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

Inappropriate use of this product, such as on large areas of the body, application on mucous membranes, or on individuals that are allergic to the amide type anesthetics, may result in serious side effects. Consultation with a doctor before using this product is strongly recommended.

PRECAUTIONS

Repeated doses of lidocaine 4% cream may increase blood levels of lidocaine. Avoid contact with the eyes. If eye contact occurs, immediately wash out the eye with water or saline.

The patient should be aware that dermal analgesia may be accompanied by the block of all sensations in the treated skin. For this reason, the patient should avoid inadvertent trauma to the treated area by scratching, rubbing or exposure to extreme hot or cold temperatures until complete sensation has returned.

DRUG INTERACTIONS

Lidocaine 4% cream should be used with caution in patients receiving Class I antiarrhythmic agents (e.g., tocainide, mexiletine) since the toxic effects are potentially additive and synergistic.

DIRECTIONS

HOW SUPPLIED

NDC 52565-122-07 (5 x 5 gram tubes)
NDC 52565-122-15 (15 gram tubes)
NDC 52565-122-30 (30 gram tubes)

Store at USP controlled room temperature 20° to 25°C (68° to 77°F).  

Manufactured by:
Teligent Pharma, Inc.
Buena, New Jersey 08310

PI-122-01
Revised 09/2018

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 52565-122-15

Lidocaine Cream 4%

Net Wt. 15 grams

For Topical Use Only
Do Not Use in the Eyes

15g carton PDP
LIDOCAINE 4% CREAM 
lidocaine cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:52565-122
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
Butylated Hydroxytoluene (UNII: 1P9D0Z171K)  
Cetostearyl Alcohol (UNII: 2DMT128M1S)  
Citric Acid Acetate (UNII: DSO12WL7AU)  
Edetate Disodium Anhydrous (UNII: 8NLQ36F6MM)  
Light Mineral Oil (UNII: N6K5787QVP)  
Methylparaben (UNII: A2I8C7HI9T)  
Polyoxyl 20 Cetostearyl Ether (UNII: YRC528SWUY)  
Propylparaben (UNII: Z8IX2SC1OH)  
Water (UNII: 059QF0KO0R)  
Sodium Citrate, Unspecified Form (UNII: 1Q73Q2JULR)  
Petrolatum (UNII: 4T6H12BN9U)  
Propylene Glycol (UNII: 6DC9Q167V3)  
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:52565-122-075 in 1 CARTON01/22/2019
15 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:52565-122-151 in 1 CARTON01/22/2019
215 g in 1 TUBE; Type 0: Not a Combination Product
3NDC:52565-122-301 in 1 CARTON01/22/2019
330 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34801/22/2019
Labeler - Teligent Pharma, Inc. (011036910)
Establishment
NameAddressID/FEIBusiness Operations
Teligent, Inc.011036910manufacture(52565-122)

Revised: 1/2019
Document Id: a8eeed92-d89f-4119-b862-31e1f91f6b21
Set id: a3216e25-82bb-4905-ac0b-b2ef4aa32ea0
Version: 3
Effective Time: 20190122
 
Teligent Pharma, Inc.